X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12105) 12105
oncology (8537) 8537
female (6708) 6708
male (6055) 6055
high-dose chemotherapy (5897) 5897
middle aged (5371) 5371
adult (5315) 5315
hematology (4985) 4985
chemotherapy (4714) 4714
antineoplastic combined chemotherapy protocols - therapeutic use (3583) 3583
aged (3555) 3555
treatment outcome (3166) 3166
cancer (3047) 3047
transplantation (2927) 2927
adolescent (2295) 2295
prognosis (2123) 2123
combined modality therapy (2052) 2052
therapy (1857) 1857
transplantation, autologous (1844) 1844
stem-cell transplantation (1760) 1760
bone-marrow-transplantation (1727) 1727
care and treatment (1683) 1683
hematopoietic stem cell transplantation (1681) 1681
retrospective studies (1603) 1603
high-dose therapy (1561) 1561
child (1553) 1553
disease-free survival (1518) 1518
bone-marrow transplantation (1515) 1515
immunology (1507) 1507
antineoplastic agents - therapeutic use (1367) 1367
colony-stimulating factor (1346) 1346
high-dose methotrexate (1338) 1338
non-hodgkins-lymphoma (1334) 1334
antineoplastic combined chemotherapy protocols - adverse effects (1314) 1314
survival analysis (1314) 1314
survival (1313) 1313
pharmacology & pharmacy (1301) 1301
survival rate (1290) 1290
stem cells (1279) 1279
antineoplastic combined chemotherapy protocols - administration & dosage (1167) 1167
medicine & public health (1149) 1149
radiotherapy (1112) 1112
cyclophosphamide (1103) 1103
child, preschool (1034) 1034
risk factors (1025) 1025
follow-up studies (998) 998
animals (995) 995
health aspects (983) 983
neoplasm staging (970) 970
stem cell transplantation (953) 953
research (943) 943
cisplatin (935) 935
multiple myeloma (932) 932
phase-ii (918) 918
randomized-trial (900) 900
hematology, oncology and palliative medicine (899) 899
remission induction (891) 891
antineoplastic agents - adverse effects (879) 879
recurrence (864) 864
phase-ii trial (848) 848
children (845) 845
aged, 80 and over (841) 841
hematopoietic stem cells (818) 818
dose-response relationship, drug (815) 815
trial (815) 815
cyclophosphamide - administration & dosage (802) 802
young adult (799) 799
salvage therapy (787) 787
etoposide (783) 783
hematopoietic stem cell transplantation - methods (775) 775
time factors (765) 765
analysis (764) 764
bone marrow transplantation (759) 759
pediatrics (754) 754
lymphoma (753) 753
drug administration schedule (743) 743
medicine, general & internal (742) 742
surgery (739) 739
toxicity (738) 738
lymphomas (737) 737
multiple myeloma - therapy (729) 729
clinical trials as topic (714) 714
etoposide - administration & dosage (676) 676
cisplatin - administration & dosage (663) 663
prospective studies (663) 663
breast cancer (655) 655
leukemia (647) 647
randomized trial (643) 643
antineoplastic agents - administration & dosage (621) 621
high-dose cytarabine (620) 620
combination chemotherapy (618) 618
rituximab (617) 617
tumors (616) 616
infant (611) 611
high-dose melphalan (610) 610
breast-cancer (609) 609
carcinoma (607) 607
autologous transplantation (606) 606
methotrexate (605) 605
neoplasms - drug therapy (589) 589
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15136) 15136
German (306) 306
French (230) 230
Japanese (88) 88
Russian (68) 68
Spanish (67) 67
Polish (23) 23
Portuguese (22) 22
Czech (21) 21
Italian (21) 21
Korean (10) 10
Chinese (7) 7
Turkish (6) 6
Hungarian (5) 5
Slovenian (3) 3
Dutch (2) 2
Serbian (2) 2
Esperanto (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BMC cancer, ISSN 1471-2407, 2016, Volume 16, Issue 1, p. 282
Journal Article
Cochrane library, ISSN 1465-1858, 2017, Volume 2017, Issue 8, pp. CD004064 - CD004064
... to HER‐2 positive disease treated with trastuzumab, in combination with chemotherapy, in first... 
Camptothecin | Stomach | Anthracyclines | Gastroenterology & hepatology | Cancer: other gastrointestinal | Palliation | Docetaxel | Antineoplastic Combined Chemotherapy Protocols | Cisplatin | Randomized Controlled Trials as Topic | Irinotecan | Chemotherapy | Treatment | Taxoids | Stomach Neoplasms | Medicine General & Introductory Medical Sciences | Fluorouracil | Cancer | 1ST-LINE TREATMENT | OLDER-ADULT PATIENTS | COLONY-STIMULATING FACTOR | Humans | Anthracyclines [administration & dosage] | Cisplatin [administration & dosage] | HIGH-DOSE 5-FLUOROURACIL | Fluorouracil [administration & dosage] | MEDICINE, GENERAL & INTERNAL | analogs & derivatives | RANDOMIZED PHASE-II | ADVANCED GASTROINTESTINAL CANCER | mortality | Taxoids [administration & dosage] | Antineoplastic Combined Chemotherapy Protocols [therapeutic use] | QUALITY-OF-LIFE | GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA | Camptothecin [administration & dosage | Stomach Neoplasms [drug therapy | S-1 PLUS CISPLATIN | COOPERATIVE-ONCOLOGY-GROUP | Stomach Neoplasms - drug therapy | Cisplatin - administration & dosage | Taxoids - administration & dosage | Anthracyclines - administration & dosage | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Camptothecin - administration & dosage | Stomach Neoplasms - mortality | Camptothecin - analogs & derivatives | Index Medicus
Journal Article
Cancer treatment reviews, ISSN 0305-7372, 2014, Volume 40, Issue 7, pp. 872 - 882
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 10, pp. 1396 - 1408
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9701, pp. 1639 - 1651
Journal Article